Mitacs Clinical Trials
Sponsors / Mitacs
22 ClinicalTrials.gov entries name Mitacs as the lead sponsor. The portfolio currently includes 4 recruiting studies, 4 active non-recruiting studies, and 7 completed studies. 2 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment. Cumulative planned enrollment across all listed trials is 3,991 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
22
Total Trials
4
Recruiting
4
Other Active
7
Completed
2
Terminated / Withdrawn
3,991
Total Enrollment
Termination reasons: Other50% · Recruitment50%
Recent Terminations
- Aging"COVID-19 forced the shut down of the study"
- Cardiovascular Disease"Inability to recruit"
Active Trials (4 total)
- NCT06942208
- NCT05447312
- NCT06315127
- NCT06269913
- NCT06338787
- NCT05633706
- Major Depressive Diorder PHASE1NCT06719427
- NCT06846047